Baker Amir, Klimscha Walter, Eisenach James C, Li Xin-Hui, Wildling Eckart, Menth-Chiari Wolfgang A, Chiari Astrid I
*Department of Anesthesiology and General Intensive Care, University of Vienna, Vienna, Austria; †Department of Anesthesiology and Center for the Study of Pharmacologic Plasticity in the Presence of Pain, Wake Forest University School of Medicine, Winston-Salem, North Carolina; and ‡Department of Traumatology, University of Vienna, Vienna, Austria.
Anesth Analg. 2004 Jul;99(1):128-134. doi: 10.1213/01.ANE.0000114549.17864.36.
Intrathecal (IT) clonidine is an effective analgesic, but it also produces hemodynamic depression and sedation which are likely to be related to IT clonidine's cephalad spread within the cerebrospinal fluid. We hypothesized that IT clonidine's side effects could be reduced without compromising the duration and quality of analgesia by injecting clonidine IT in a hyperbaric solution and elevating the patient's trunk. We prospectively randomized 30 elderly patients to receive IT 150 microg of either isobaric (ISO) or hyperbaric (HYPER) clonidine for postoperative analgesia after surgical repair of traumatic hip fracture. Hemodynamics, IV fluid administration, visual analog pain scores, sedation scores, and clonidine cerebrospinal fluid levels were recorded at fixed intervals. Patients in the ISO group required significantly more crystalloid fluid administration (median, 2500 mL; range, 1500-3000 mL) than those in the HYPER group (median, 1500; range, 500-3000 mL) to maintain adequate arterial blood pressure (P < 0.01). Also, the decrease in heart rate was significantly more pronounced in the ISO than in the HYPER group (P < 0.01). The duration of analgesia was significantly larger in the ISO (median, 400 min; range, 115-400 min) than in the HYPER (median, 265 min; range, 205-400 min) group (P < 0.05). Sedation scores did not differ between groups. We conclude that increasing the baricity of IT clonidine solution in the conditions of our experiment reduces hemodynamic side effects but also analgesia from IT administered clonidine.
鞘内注射可乐定是一种有效的镇痛方法,但它也会引起血流动力学抑制和镇静作用,这可能与鞘内注射可乐定在脑脊液中向头端扩散有关。我们推测,通过在高比重溶液中注射可乐定并抬高患者躯干,在不影响镇痛持续时间和质量的情况下,可减少鞘内注射可乐定的副作用。我们前瞻性地将30例老年患者随机分为两组,分别接受等比重(ISO)或高比重(HYPER)的150微克鞘内可乐定注射,用于创伤性髋部骨折手术修复后的术后镇痛。在固定时间间隔记录血流动力学、静脉输液量、视觉模拟疼痛评分、镇静评分和可乐定脑脊液水平。ISO组患者为维持足够的动脉血压,所需晶体液输注量(中位数,2500毫升;范围,1500 - 3000毫升)显著多于HYPER组(中位数,1500毫升;范围,500 - 3000毫升)(P < 0.01)。此外,ISO组心率下降比HYPER组更显著(P < 0.01)。ISO组的镇痛持续时间(中位数,400分钟;范围,115 - 400分钟)显著长于HYPER组(中位数,265分钟;范围,205 - 400分钟)(P < 0.05)。两组间镇静评分无差异。我们得出结论,在我们的实验条件下增加鞘内可乐定溶液的比重可减少血流动力学副作用,但也会降低鞘内注射可乐定的镇痛效果。